Literature DB >> 18942660

Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.

Erin Winters Ulloa1, Raoul Salup, Stephen G Patterson, Paul B Jacobsen.   

Abstract

OBJECTIVE: Side effects of cancer treatment have been found to have a significant impact on patients' psychological well-being. Each of the primary treatment options for prostate cancer is associated with significant side effects that can have a dramatic impact on quality of life. Hot flashes are a notable side effect of androgen deprivation therapy (ADT) and a potential source of distress due to their episodic nature and low frequency in a normal aging male population. The current study sought to examine the relationship between hot flashes and cancer-related distress during the first three months of ADT.
METHODS: Participants were 68 men with various stages of prostate cancer scheduled to begin ADT for the first time. Study measures were completed at the beginning of treatment and 3 months later.
RESULTS: Repeated measures ANOVA indicated that men who did not experience hot flashes had a significant decrease in total cancer-related distress and avoidance over the 3-month period, while men with hot flashes exhibited no change in distress. Among men with hot flashes, results of hierarchical regression analyses indicated that a worse experience with hot flashes was a significant predictor of greater increases in intrusion and total cancer-related distress over the 3-month period.
CONCLUSIONS: These results suggest that hot flashes serve to maintain levels of distress during the treatment period. Further research should extend these findings by lengthening the follow-up period and using ecological momentary assessment to refine measurement of these constructs and provide evidence for the direction of causality between hot flashes and distress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18942660     DOI: 10.1002/pon.1427

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  5 in total

1.  Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.

Authors:  Brian D Gonzalez; Heather S L Jim; Margaret Booth-Jones; Brent J Small; Steven K Sutton; Hui-Yi Lin; Jong Y Park; Philippe E Spiess; Mayer N Fishman; Paul B Jacobsen
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 44.544

2.  Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison.

Authors:  Brian D Gonzalez; Heather S L Jim; Kristine A Donovan; Brent J Small; Steve K Sutton; Jong Park; Hui-Yi Lin; Philippe E Spiess; Mayer N Fishman; Paul B Jacobsen
Journal:  J Urol       Date:  2015-03-16       Impact factor: 7.450

3.  Cognitive impairment in men treated with luteinizing hormone-releasing hormone agonists for prostate cancer: a controlled comparison.

Authors:  Heather S L Jim; Brent J Small; Stephen Patterson; Raoul Salup; Paul B Jacobsen
Journal:  Support Care Cancer       Date:  2009-04-03       Impact factor: 3.603

4.  Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.

Authors:  Brian D Gonzalez; Brent J Small; Mallory G Cases; Noelle L Williams; Mayer N Fishman; Paul B Jacobsen; Heather S L Jim
Journal:  Cancer       Date:  2017-10-26       Impact factor: 6.860

5.  A randomised controlled trial of a brief cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN).

Authors:  Evgenia Stefanopoulou; Omar Yousaf; Elizabeth A Grunfeld; Myra S Hunter
Journal:  Psychooncology       Date:  2015-03-09       Impact factor: 3.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.